
From barriers to implementing evidence-based care to innovations in combination therapy, here are 5 key updates from the annual meeting.

Neha Pagidipati, MD, MPH, is an assistant professor of medicine and cardiovascular disease prevention specialist at Duke University School of Medicine.

From barriers to implementing evidence-based care to innovations in combination therapy, here are 5 key updates from the annual meeting.

Pagidipati describes barriers to implementing guideline-directed medical therapy in patients with cardiometabolic diseases and steps needed to overcome them.